Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare

L Marques, B Costa, M Pereira, A Silva, J Santos… - Pharmaceutics, 2024 - mdpi.com
The landscape of medical treatments is undergoing a transformative shift. Precision
medicine has ushered in a revolutionary era in healthcare by individualizing diagnostics and …

Artificial intelligence and machine learning approaches to facilitate therapeutic drug management and model-informed precision dosing

EA Poweleit, AA Vinks, T Mizuno - Therapeutic drug monitoring, 2023 - journals.lww.com
Background: Therapeutic drug monitoring (TDM) and model-informed precision dosing
(MIPD) have greatly benefitted from computational and mathematical advances over the …

Artificial intelligence in pharmacology research and practice

M Van der Lee, JJ Swen - Clinical and Translational Science, 2023 - Wiley Online Library
In recent years, the use of artificial intelligence (AI) in health care has risen steadily,
including a wide range of applications in the field of pharmacology. AI is now used …

Bridging the worlds of pharmacometrics and machine learning

K Stankevičiūtė, JB Woillard, RW Peck… - Clinical …, 2023 - Springer
Precision medicine requires individualized modeling of disease and drug dynamics, with
machine learning-based computational techniques gaining increasing popularity. The …

Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: the example of tacrolimus

JB Woillard, M Labriffe, A Prémaud, P Marquet - Pharmacological research, 2021 - Elsevier
We previously demonstrated that Machine learning (ML) algorithms can accurately estimate
drug area under the curve (AUC) of tacrolimus or mycophenolate mofetil (MMF) based on …

A machine learning approach to predict interdose vancomycin exposure

M Bououda, DW Uster, E Sidorov, M Labriffe… - Pharmaceutical …, 2022 - Springer
Introduction Estimation of vancomycin area under the curve (AUC) is challenging in the case
of discontinuous administration. Machine learning approaches are increasingly used and …

Machine learning: a new approach for dose individualization

QY Li, BH Tang, YE Wu, BF Yao… - Clinical …, 2024 - Wiley Online Library
The application of machine learning (ML) has shown promising results in precision medicine
due to its exceptional performance in dealing with complex multidimensional data. However …

[HTML][HTML] Artificial intelligence, big data and heart transplantation: Actualities

V Palmieri, A Montisci, MT Vietri, PC Colombo… - International Journal of …, 2023 - Elsevier
Background As diagnostic and prognostic models developed by traditional statistics perform
poorly in real-world, artificial intelligence (AI) and Big Data (BD) may improve the supply …

Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles

M Labriffe, JB Woillard, J Debord… - CPT: Pharmacometrics …, 2022 - Wiley Online Library
Everolimus is an immunosuppressant with a small therapeutic index and large between‐
patient variability. The area under the concentration versus time curve (AUC) is the best …

A hybrid model associating population pharmacokinetics with machine learning: a case study with iohexol clearance estimation

A Destere, P Marquet, CS Gandonnière… - Clinical …, 2022 - Springer
Abstract Background Maximum a posteriori Bayesian estimation (MAP-BE) based on a
limited sampling strategy and a population pharmacokinetic model is frequently used to …